Okay, let's tackle this question. The patient is a 40-year-old female with anemia, jaundice, and spherocytosis. The key here is to figure out the appropriate investigation.

First, I remember that spherocytosis is a red blood cell membrane defect, leading to hemolysis. The classic triad is anemia, jaundice, and spherocytes on peripheral blood smear. The most common hereditary spherocytosis is due to defects in proteins like spectrin, ankyrin, band 3, or protein 4.2. So, the main issue is hemolytic anemia from RBC destruction.

The next step is to confirm the diagnosis. The peripheral blood smear already shows spherocytosis, which is a strong indicator. But to confirm hereditary spherocytosis, specific tests are needed. One of the key tests is the osmotic fragility test. Spherocytes are more fragile in hypotonic solutions, so this test would show increased fragility.

Now, looking at the options (though they're not listed here), the correct answer should be the osmotic fragility test. Other options might include Coombs test for AIHA, which is negative in hereditary cases. G6PD deficiency is another cause of hemolysis but doesn't present with spherocytosis. Bone marrow biopsy isn't typically needed here.

Wait, but wait. Sometimes, the direct antiglobulin test (DAT) is done to rule out autoimmune hemolytic anemia. In hereditary spherocytosis, DAT is usually negative. So if DAT is positive, it's AIHA. But the question is about the most appropriate investigation. Since the blood smear already shows spherocytosis, the next step is to confirm the diagnosis with osmotic fragility.

So the correct answer is osmotic fragility test. The other options are either for differentials or not specific enough. The clinical pearl here is that hereditary spherocytosis is confirmed by osmotic fragility and family history. Also, remember that in AIHA, the DAT is positive, which is a key differentiator.

**Core Concept**
Hereditary spherocytosis (HS) is an autosomal dominant red blood cell membrane disorder causing chronic hemolytic anemia. The diagnosis hinges on identifying spherocytes on peripheral blood smear and confirming increased RBC osmotic fragility due to defects in proteins like spectrin or ankyrin.

**Why the Correct Answer is Right**
The osmotic fragility test is the gold standard for confirming HS. Spherocytes lack the normal membrane surface area-to-volume ratio, making them more susceptible to lysis in hypotonic solutions. This test quantifies the abnormal fragility, distinguishing HS from other hemolytic anemias like autoimmune hemolytic anemia (AIHA) or G6PD deficiency.

**Why Each Wrong Option is Incorrect**
**Option A:** Coombs test (direct antiglobulin test) is incorrect because it detects antibodies on RBCs in AIHA, which is negative in HS.
**Option B:** G6PD deficiency testing is irrelevant here, as G6PD deficiency causes hemolysis post-oxidant exposure but does not produce spherocytes.
**Option C:** Bone

✓ Correct Answer: B. Coomb's test